Northern Trust’s Aravive, Inc. Common Stock ARAV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-74,696
| Closed | -$9.24K | – | 4543 |
|
|
2023
Q4 | $9.24K | Hold |
74,696
| – | – | ﹤0.01% | 4425 |
|
|
2023
Q3 | $9.86K | Buy |
74,696
+132
| +0.2% | +$83 | ﹤0.01% | 4403 |
|
|
2023
Q2 | $94K | Buy |
74,564
+8,839
| +13% | +$14.3K | ﹤0.01% | 4052 |
|
|
2023
Q1 | $131K | Sell |
65,725
-8,804
| -12% | -$16.5K | ﹤0.01% | 4006 |
|
|
2022
Q4 | $98.4K | Buy |
74,529
+36,099
| +94% | +$46.1K | ﹤0.01% | 4095 |
|
|
2022
Q3 | $31K | Buy |
38,430
+5,556
| +17% | +$4.78K | ﹤0.01% | 4455 |
|
|
2022
Q2 | $32K | Hold |
32,874
| – | – | ﹤0.01% | 4541 |
|
|
2022
Q1 | $63K | Sell |
32,874
-522
| -2% | -$1.12K | ﹤0.01% | 4478 |
|
|
2021
Q4 | $73K | Sell |
33,396
-287
| -0.9% | -$954 | ﹤0.01% | 4512 |
|
|
2021
Q3 | $125K | Sell |
33,683
-2,538
| -7% | -$10.8K | ﹤0.01% | 4343 |
|
|
2021
Q2 | $217K | Sell |
36,221
-106,255
| -75% | -$562K | ﹤0.01% | 4131 |
|
|
2021
Q1 | $939K | Sell |
142,476
-15,198
| -10% | -$99.9K | ﹤0.01% | 3611 |
|
|
2020
Q4 | $889K | Sell |
157,674
-3,684
| -2% | -$20.2K | ﹤0.01% | 3556 |
|
|
2020
Q3 | $759K | Sell |
161,358
-24,905
| -13% | -$177K | ﹤0.01% | 3496 |
|
|
2020
Q2 | $2.17M | Buy |
186,263
+164,026
| +738% | +$1.95M | ﹤0.01% | 3006 |
|
|
2020
Q1 | $128K | Buy |
22,237
+100
| +0.5% | +$896 | ﹤0.01% | 3770 |
|
|
2019
Q4 | $302K | Buy |
22,137
+6,344
| +40% | +$56.1K | ﹤0.01% | 3673 |
|
|
2019
Q3 | $118K | Hold |
15,793
| – | – | ﹤0.01% | 3889 |
|
|
2019
Q2 | $95K | Hold |
15,793
| – | – | ﹤0.01% | 3980 |
|
|
2019
Q1 | $111K | Buy |
15,793
+463
| +3% | +$2.42K | ﹤0.01% | 3905 |
|
|
2018
Q4 | $54K | Buy |
15,330
+5,121
| +50% | +$29.5K | ﹤0.01% | 4039 |
|
|
2018
Q3 | $86K | Sell |
10,209
-897
| -8% | -$9.45K | ﹤0.01% | 4054 |
|
|
2018
Q2 | $135K | Sell |
11,106
-48,461
| -81% | -$499K | ﹤0.01% | 3955 |
|
|
2018
Q1 | $590K | Sell |
59,567
-112
| -0.2% | -$1.26K | ﹤0.01% | 3522 |
|
|
2017
Q4 | $788K | Sell |
59,679
-7,583
| -11% | -$97.6K | ﹤0.01% | 3462 |
|
|
2017
Q3 | $989K | Sell |
67,262
-2,830
| -4% | -$285K | ﹤0.01% | 3438 |
|
|
2017
Q2 | $7.34M | Buy |
70,092
+9,460
| +16% | +$1.02M | ﹤0.01% | 2376 |
|
|
2017
Q1 | $7.77M | Sell |
60,632
-543
| -0.9% | -$57.3K | ﹤0.01% | 2293 |
|
|
2016
Q4 | $5.47M | Buy |
61,175
+9,497
| +18% | +$720K | ﹤0.01% | 2498 |
|
|
2016
Q3 | $3.8M | Buy |
51,678
+855
| +2% | +$61.8K | ﹤0.01% | 2699 |
|
|
2016
Q2 | $3.37M | Buy |
50,823
+10,743
| +27% | +$611K | ﹤0.01% | 2720 |
|
|
2016
Q1 | $1.93M | Sell |
40,080
-192
| -0.5% | -$10.2K | ﹤0.01% | 3007 |
|
|
2015
Q4 | $2.99M | Sell |
40,272
-681
| -2% | -$45.7K | ﹤0.01% | 2798 |
|
|
2015
Q3 | $2.83M | Buy |
40,953
+19,569
| +92% | +$1.84M | ﹤0.01% | 2827 |
|
|
2015
Q2 | $1.95M | Buy |
21,384
+6,148
| +40% | +$623K | ﹤0.01% | 3069 |
|
|
2015
Q1 | $1.68M | Buy |
15,236
+2,997
| +24% | +$352K | ﹤0.01% | 3220 |
|
|
2014
Q4 | $1.65M | Buy |
12,239
+274
| +2% | +$32K | ﹤0.01% | 3211 |
|
|
2014
Q3 | $1.36M | Buy |
11,965
+8,948
| +297% | +$1.19M | ﹤0.01% | 3312 |
|
|
2014
Q2 | $508K | Buy |
+3,017
| New | +$521K | ﹤0.01% | 3589 |
|
Other funds holding ARAV
Northern Trust's ARAV Position: Q1 2024 in Review
Northern Trust sold out of Aravive, Inc. Common Stock (ARAV) in Q1 2024, closing a stake of 74,696 shares — an estimated $9.24K sold.
Northern Trust first reported a position in ARAV in Q2 2014 and held it in 39 quarters. The position peaked at $7.77M in Q1 2017. 3 funds tracked by Wall St. Rank hold ARAV as of Q1 2024.
- Northern Trust reported no remaining Aravive, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Northern Trust sold 74,696 Aravive, Inc. Common Stock shares in Q1 2024, an estimated $9.24K.
- Northern Trust first reported a position in Aravive, Inc. Common Stock in Q2 2014 and held it in 39 quarters.
- Northern Trust's Aravive, Inc. Common Stock position peaked at $7.77M in Q1 2017.
- 3 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q1 2024.
Based on Northern Trust's 13F filing for Q1 2024, filed 14 May 2024.